[MUSIC]
President Trump arrives in Beijing for a summit with China's Xi Jinping. >> Our co-host Steve Inskeep is there with NPRs Jennifer Pack. They visit the great home where the leaders will meet and talk about what's at stake for the world's two largest economies. >> I'm Leila Faldin, that's Michelle Martin, and this is up first from NBR News. [MUSIC]
>> A Pentagon official told lawmakers the war in Iran has cost $29 billion so far.
Defense Secretary Pete Hegseth is asking Congress for $1.5 trillion for next year's budget. >> This is admittedly a historic budget. It is a fiscally responsible budget, and it is a warfighting budget. >> Some Republicans are joining Democrats and pushing back. >> And FDA Commissioner Dr. Martin McCary is out after 13 months on the job.
“Stay with us, we'll give you news you need to start your day.”
[MUSIC] >> From Spider-Man to a new Steven Spielberg movie, we know the TV and movies you'll want to watch this summer. >> I'm excited about this film. I just know suspense, intrigue aliens, and I'm like, all right, Spielberg, I'm in. >> Check out the summer guide from Pop Culture Happy Hour,
listen on the NPR app, or wherever you get podcasts. [MUSIC] >> Air Force One lands in Beijing soon. President Trump is there to talk with China's President Xi Jinping. >> Their summit will be brief, expectations are low,
but much as that stake in the trade war, and the president is bringing along many of the biggest corporate chief executives in the United States. >> Our colleague Steve Inskeep is in Beijing for the summit, hey there. >> By their Michelle, I'm in the center of this gigantic city, and I'm with NPR's Jennifer Pack, who's based in China,
and we're going to talk through the events of this summit that begins shortly.
“Jennifer Layla mentioned CEOs, who's the president bringing here?”
>> Well, he's bringing a bunch of CEOs from Boeing, cargo, even Nvidia. Basically companies that want to sell more to China, because many of their sales were stalled because President Trump launched a trade war last year. Trump had launched tariffs on Chinese exports, and he had imposed export controls on American high tech trying to struck back.
So they reached a kind of pause last year, but it's really fragile. So the two leaders are meeting to stabilize the relationship. Trump wants a deal. China understands that about him, and might find that easier to deal with. >> Well, I want people to know that you and I are just a few miles from this enormous building
where Trump will be welcomed on Thursday, and we want to see it. The easiest way to do that was by renting bikes, which you can do on any street in Beijing. And as we bike through traffic, we discussed what is its stake at the summit.
Here's what it sounded like.
>> Okay, so on our right is the forbidden city, and on the left is the great hall of the people. And that, and my right is where President Trump will be officially welcomed. >> Absolutely. >> On Thursday. >> You've been in that building.
What's it like in there? >> Yeah, it's like full of red, plushed carpet, chandeliers, marble walls. It's just massive. >> There's a policy argument about a summit, but there's also the symbolism of it. >> Yes, it's about face and the importance of this relationship.
That's a massive thing for Chinese officials that they need to be seen as a pure to be respected. The traffic here, and I suppose we should note, we are still approaching the great hall of the people that the Trump administration's point of view is that it has been not getting that kind of respect. He now comes here wanting the Chinese to increase or in some cases, resume purchases of American products. That's one of the things we think the United States wants out of this.
>> Absolutely, and China also wants to buy from the U.S.
“You know, one of the Chinese officials argument is if you want to rebalance the trade deficit,”
then let us China buy more top-notch semi-conductors to run our AI. >> Which is exactly what you're jet engines that we need. >> Which is exactly what we should note the Biden administration, as well as the Trump administration, has not been willing to do in recent years. The United States trying to maintain its lead in artificial intelligence.
>> Absolutely, but guess what China's leverage is, it has the crucial key minerals that American eats.
>> Rare Earths. >> Well, that's the reason why a lot of analysts say that China is coming into this summit much stronger, than they did almost 10 years ago when they last had Trump coming to China. >> Jennifer, I know we were just passing one building, but it feels like we took several minutes to do so. It's a big one.
>> It's a big one. >> And NPR's Jennifer Pack is a pretty confident on that yellow bike in Beijing traffic. >> Thanks so much. >> Thank you. [MUSIC]
>> The Pentagon estimates the cost of the war with Iran is about $29 billion.
>> Top defense officials answered questions from Congress on Tuesday. That price tag was one of a few specifics in the day of testimony. >> And PR Congressional correspondent Clutter could have saw us was watching and she's with us now. Good morning, Claudia. >> Good morning, Michelle.
>> So two weeks ago, Pentagon leaders told lawmakers that the cost of the war was $25 billion.
“Now it's $29 billion, are we any closer to a final estimate?”
>> No, and even that figure does not paint a full picture. Pentagon officials admitted that it doesn't include repairs to U.S facilities that have been hit by Iran. We heard Senate Democrat Jack Reed press Pentagon Comptroller J. Hurse on this exact question. >> So you cannot consider installations that have been damaged in the conflict, correct? >> We just don't have a good estimate this time.
>> So I talked to Mark Kansian. He's senior advisor at the Center for Strategic and International Studies. And he's been tracking the costs of the war. CSIS estimates that these repairs alone could add at least another $4 billion to the final price tag. And getting that full picture is key because the Pentagon expects to ask for supplemental funding on
top of all of this to pay for the war. >> Right, and this hearing was supposed to focus on the administration's request for one and a half trillion dollars for next year's budget. What did we learn about that? >> Right, and it's a big increase from last year's defense budget of $1 trillion.
It's the largest such ask in history. Defense Secretary P. Heggseth argues that it's part of a plan to reverse years of under investment in the military. >> We're submitting a $1.5 trillion budget that will remake the department and ensure that every war fighter in the future has exactly what they need. >> But lawmakers in both parties say they need to know how all that money is going to be spent
before they can sign off. Take a listen to House Democratic Appropriator Betty McCullum raising this. >> I'm deeply concerned that the department can't seem to manage one trillion dollars that Congress provided last year. So, gentlemen, we need information.
“>> Did we learn anything new about when the state of her moves could reopen?”
>> No, not really. Heggseth couldn't give an estimate when that could happen.
He said the U.S. controls the state and U.S. military pressure is a key point of leverage against
Iran, but many Democrats questioned that claim. Connecticut Senator Chris Murphy argued there's essentially no military mechanism to reopen the state. He said the administration strategy to use economic pressure is high risk. >> When there's plenty of evidence from military history to show the countries that are being
attacked or invaded or occupied, are actually willing to put up with a whole lot of economic misery in order to preserve national pride. >> Okay, well, what about Republicans? Did any Republicans push back against Heggseth and other officials? >> Yes, they took officials to task quite a few times.
We saw Maine Senator Susan Collins race concerns that there seemingly is a shifting plan to reopen the state in South Carolina's Lindsey Graham question, Pakistan's role as a mediator in talks
“with Iran, and we also saw Alaska Senator Lisa Murkowski race concerned about the ceasefire”
that does not look like a ceasefire. And it's clear, where more than two months into this war and we're seeing increasing GOP frustration about a lack of information from the White House. And this is creating political headwins for Republicans is to get ready to face voters as fall who are unhappy with the war and think daily reminders of it at the gas pump and elsewhere
in the economy. That is NPR's Claudia Grisal's Claudia, thank you. >> Thank you. >> The commissioner of the food and drug administration is gone. >> Yeah, Dr. Marty McCary resigned Tuesday after 13 tumultuous months on the job.
>> NPR pharmaceuticals corresponded to say that your love can is here to talk about the change of what I'm sending. >> Good morning, so why is this happening? >> Well, I told the final straw for McCary was White House pressure to okay flavored vapes, something he did not agree with.
That's according to a federal health official familiar with management of the agency, but who wasn't authorized to speak publicly. The pressure has been building for a while. He had survived a series of controversies. McCary was definitely disrupting the agency, which is really in line with what the rest of the
Trump administration has been trying to do to the federal government. And he made a lot of people mad. At times, McCary angered the Make America healthy again movement for not pushing the Maha agenda fast enough or hard enough. And he upset people wanting a more predictable approach to regulation at the FDA.
>> Can you give us some examples? >> Oh, short, for example, people who support the Maha movement were upset when the agency approved updated COVID-19 vaccines last year.
He also disappointed people who oppose abortion by approving a second generic version of
Mithra Pristone drug makers and patient groups who won a consistent and predictable FDA were
Unhappy with the agency's referrals on experimental drugs and vaccines.
McCary made some policy changes without convening the typical FDA advisory committees of
outside experts.
“These committees have a lot of rules around them to make sure they're not biased and they're”
typically convened before big agency decisions. It's a way to build public trust. And McCary didn't do that before changing the safety warnings on a hormone replacement therapies.
At the time, he called the committees bureaucratic, conflicted, and expensive.
So even though medical groups had long wanted those safety labels changed, they didn't like the way McCary did it.
“>> So what are people saying now that McCary is out?”
>> In a post on truth, social, president Trump, thanked McCary for doing a great job. But Dr. Ben Rome, a physician and health policy researcher at Brigham and Women's Hospital in Boston, says he's glad to see McCary go. >> I think the last year has been an unmedicated disaster for the FDA. So there has been a lot of changes to regulatory processes that have totally undermined
the FDA's independent abilities and have introduced political interference into the process. >> There's also been a big exodus of career staff that's in addition to the mass firings that took place just after McCary was confirmed last year. Rome says he hopes the next person will write the ship, but he's worried.
“>> So speaking of that, who is the next person that we think will lead the FDA?”
>> That would be Kyle Diamantis, Trump announced that he'll be the acting commissioner. Diamantis had been the deputy commissioner for food overseeing nutrition and human food safety. He's a lawyer, not a medical doctor. But the administration has struggled to get some of its health picks confirmed by the Senate. So it may be a while before there's a permanent commissioner.
>> That is, NPR's pharmaceuticals correspondent, City Lock and City Thank You. >> You bet.
>> And it's up first for Wednesday, May 13th, I'm Michelle Martin.
>> And I'm Leyla Faldin. >> Today's episode of Up First was edited by Miguel Macias, Jason Brezlo, Chris Houston, Muhammad that by DC and John Stoleness. It was produced by Ziyad Bunch and the Adomass, our director, is Christopher Thomas. We get engineering support from the Shahinis, our technical director is Carly Strange,
and our supervising producer is Michael Lipkin. Join us again tomorrow. [ Music ]
